🇺🇸 FDA

Intelligence · Patent portfolio

Regeneron Ireland Designated Patents

Full USPTO pharma patent portfolio for Regeneron Ireland Designated — grant dates, expiration, and drug cross-links.

Patents
8,292
Expiring ≤24m
426

Quick answer

Regeneron Ireland Designated has 8,292 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 426 expire within 24 months — use filters for patent-cliff planning.

Page 26 of 173

  1. US 11478556

    Compositions and methods for treating or ameliorating neuroinflammation, neurodegeneration, neuropathic pain, and migraine

    Expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11479774

    Methods of treating cancer harboring hemizygous loss of TP53

    Expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11479530

    Synthetic sphingolipid-like molecules, drugs, methods of their synthesis and methods of treatment

    Expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11478502

    Methods and compositions for administration of iron

    Expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11478517

    Live attenuated recombinant HMPV with mutations in PDZ motifs of M2-2 protein, vaccine containing and use thereof

    Expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11478510

    Chimeric antigen receptor and methods of use thereof

    Expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11479775

    RNA targeting of mutations via suppressor tRNAs and deaminases

    Expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11479772

    Thiomorpholino oligonucleotides for the treatment of muscular dystrophy

    Expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11478489

    Selective accretion of cytoprotectant in radiation-sensitive tissues and uses thereof

    Expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11478568

    Radioactive cement

    Expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11479601

    Antibodies specific to Sonic Hedgehog and method of use thereof

    Expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11478500

    Anticancer compositions and methods for making and using them

    Expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11479560

    OX2R compounds

    Expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11478571

    Synthetic hydrogel carriers for cellular structures, generation of organoids, and treatment of tissue injury

    Expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11479579

    Therapeutic compounds and methods

    Expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11471496

    Compositions and methods for treating or ameliorating cocaine addiction

    Expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11471509

    Compositions and methods relating to myomaker-induced muscle cell fusion

    Expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11471517

    Compositions and methods for preventing and treating graft versus host disease

    Expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11471449

    Use of pridopidine to improve cognitive function and for treating Alzheimer's disease

    Expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11472804

    Compositions and methods for modulating hair growth

    Expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 11472888

    Reelin antibodies for treatment of atherosclerosis

    Expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 11472813

    OX2R compounds

    Expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 11473108

    Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

    Expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 11472859

    Method and composition for treating neuronal hyper-excitabtiity

    Expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 11472812

    Anti-cancer compounds targeting Ral GTPases and methods of using the same

    Expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 11466010

    Toll-like receptor 8 (TLR8) specific antagonists and methods of making and uses thereof

    Expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 11466261

    Mutated PTE enzymes

    Expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 11464886

    Controllable self-annealing microgel particles for biomedical applications

    Expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 11466017

    Heterocyclic inhibitors of PTPN11

    Expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 11464784

    Inhibition of aminocylase 3 (AA3) in the treatment of cancer

    Expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 11466028

    Fused 1,4-oxazepines as BET protein degraders

    Expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 11464843

    Use of the salmonella SPP type III secretion proteins as a protective vaccination

    Expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 11466055

    Virus-like nanoparticles for oral delivery

    Expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 11465998

    Therapeutic compounds and methods of use thereof

    Expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 11459564

    Modulation of frataxin expression

    Expires Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 11458203

    Pharmaceutical compositions comprising caffeic acid chelates

    Expires Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 11459560

    Methods and compositions for reprogramming cells

    Expires Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 11459617

    Targeted measure of transcriptional activity related to hormone receptors

    Expires Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 11458212

    Molecular imaging of cancer cells in vivo

    Expires Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 11458136

    Antiviral prodrugs and formulations thereof

    Expires Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 11458107

    Abiotic anti-VEGF nanoparticle

    Expires Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 11459385

    Anti-IL-2 antibodies and compositions and uses thereof

    Expires Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 11458094

    Compositions and methods for treating pulmonary edema or lung inflammation

    Expires Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 11452780

    Mtorc1 inhibitors

    Expires Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 11452724

    Methods for treating amyotrophic lateral sclerosis

    Expires Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 11453700

    Peptide having activities of skin whitening and uses thereof

    Expires Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 11452709

    Compositions and methods for preventing and treating radiation-induced bystander effects caused by radiation or radiotherapy

    Expires Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 11453891

    Directed editing of cellular RNA via nuclear delivery of CRISPR/CAS9

    Expires Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Regeneron Ireland Designated have?

8,292 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Regeneron Ireland Designated patents expire?

426 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.